Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
result time | when the result became available | The result time was 11:30 for the specimen collected at 07:42. | Objective | Drug levels - collection and dose timing |
amended result | laboratory result formally revised after initial reporting | The amended result lists the corrected specimen time. | Objective | Drug levels - analyte, specimen and reporting |
critical result read-back | recipient repeats an urgent result to confirm accurate communication | Document the critical result read-back with the recipient, time, analyte and units. | Plan | Documentation, follow-up and transitions |
dilute Russell viper venom time | venom-based clotting assay used in lupus anticoagulant testing | Dilute Russell viper venom time was reported with screening and confirmation results. | Objective | Coagulation, antibodies and hemostasis studies |
timeframe | when a planned action should occur | Specify a timeframe for reviewing the pending result. | Plan | Follow-up, contingency and functional care |
| clock reference used by the reporting facility | Confirm the time zone on records transferred across state lines. | Plan | Monitoring actions, escalation and result communication | |
turnaround time | expected interval before a test or service is completed | Confirm the expected turnaround time before scheduling result review. | Plan | Specimen collection, imaging and follow-up procedures |
intraindividual variability | change in a parameter or result within the same person over time | The repeated levels suggest intraindividual variability across illness episodes. | Assessment | Drug concentrations, exposure and assay interpretation |
serologic response | change in antibody-based test results over time | The specialist will interpret the serologic response using paired assays. | Assessment | Infection, inflammation and evidence interpretation |
confirmatory specimen | new sample collected to verify an earlier result | Obtain a confirmatory specimen from a separate draw and record the collection time. | Plan | Documentation, follow-up and transitions |
critical callback | return contact about a laboratory-defined critical result | Document the time and recipient of the critical callback. | Plan | Monitoring actions, escalation and result communication |
critical notification | communication required by the laboratory's critical-result policy | Document the time, recipient and readback of the critical notification. | Plan | Drug levels - verification and documentation |
critical value escalation | contacting the appropriate clinician about a result meeting a critical threshold | Record critical value escalation with the value, recipient and time. | Plan | Sampling, laboratory verification and communication |
digoxin | cardiac glycoside for which dose-to-draw time affects concentration interpretation | The digoxin result was collected two hours after the reported dose. | Objective | Drug levels - named analytes and exposure reports |
follow-up interval | time before the next planned review | Record the follow-up interval and who will review the result. | Plan | Monitoring actions, escalation and result communication |
methotrexate | antimetabolite with protocol-timed levels in high-dose treatment | The methotrexate result is identified by hours from the protocol-defined infusion start. | Objective | Drug levels - named analytes and exposure reports |
outstanding test | ordered investigation whose result has yet to be received | Name the reviewer and due time for each outstanding test. | Plan | Monitoring actions, escalation and result communication |
paired sample labeling | explicitly identifying which of two results belongs to each sampling event | Confirm paired sample labeling before sending the timed specimens. | Plan | Sampling, laboratory verification and communication |
| result has not yet been reported | Blood culture results pending at the time of review. | Objective | Laboratory, imaging and test descriptors | |
serial levels | multiple results in chronological order | The serial levels are listed alongside their respective draw times. | Objective | Drug levels - collection and dose timing |
symptom correlation | linking a reported symptom to a measurement or exposure over time | Review the diary for symptom correlation with the concentration changes. | Plan | Monitoring actions, escalation and result communication |
trend review | comparison across serial results with relevant context | Document a trend review using samples collected at comparable times. | Plan | Monitoring actions, escalation and result communication |
urgent review | assessment requested on a short timeframe for a stated concern | Request urgent review of the flagged result by the responsible clinician. | Plan | Monitoring actions, escalation and result communication |
gentamicin | aminoglycoside monitored using regimen-specific sampling | The gentamicin result is paired with the infusion end time and draw time. | Objective | Drug levels - named analytes and exposure reports |
laboratory addendum | additional laboratory information after the initial report | Review the laboratory addendum for the revised specimen time. | Plan | Monitoring actions, escalation and result communication |